General Partner Inc
NVO icon

General Partner Inc’s Novo Nordisk NVO Stock Holding History

General Partner Inc’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$78.9K Hold
2,080
– – 0.04% 120
2026
Q2 		$100K Hold
2,080
– – 0.05% 111
2026
Q1 		$76.4K Hold
2,080
– – 0.05% 115
2025
Q4 		$106K Hold
2,080
– – 0.06% 105
2025
Q3 		$115K Hold
2,080
– – 0.06% 104
2025
Q2 		$144K Hold
2,080
– – 0.08% 99
2025
Q1 		$144K Buy
2,080
+1,200
+136% +$99.1K 0.09% 92
2024
Q4 		$75.7K Hold
880
– – 0.05% 115
2024
Q3 		$105K Hold
880
– – 0.07% 99
2024
Q2 		$126K Hold
880
– – 0.08% 94
2024
Q1 		$113K Buy
+880
New +$105K 0.07% 101

Other funds holding NVO

Saratoga Research & Investment Management
Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return
Euro Pacific Asset Management
Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return
Nichols & Pratt Advisers
Nichols & Pratt Advisers Boston, Massachusetts $1.68B AUM 20.22% 1-Year Est. Return
Corda Investment Management
Corda Investment Management Houston, Texas $1.52B AUM 30.53% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
QV Investors
QV Investors Calgary, Alberta, Canada $1.36B AUM 20.86% 1-Year Est. Return
Cantor Fitzgerald Investment Advisors
Cantor Fitzgerald Investment Advisors New York $1.81B AUM 23.74% 1-Year Est. Return
Penbrook Management
Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Viking Fund Management
Viking Fund Management Minot, North Dakota $1.14B AUM 32.65% 1-Year Est. Return

General Partner Inc's NVO Position: Q3 2026 in Review

General Partner Inc held its Novo Nordisk (NVO) position steady in Q3 2026 at 2,080 shares worth $78.9K. The position accounts for 0.04% of the portfolio, ranked #120.

General Partner Inc first reported a position in NVO in Q1 2024 and has held it in 11 quarters since. The position peaked at $144K in Q1 2025. 338 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • General Partner Inc held 2,080 shares of Novo Nordisk worth $78.9K as of Q3 2026.
  • General Partner Inc left its Novo Nordisk share count unchanged in Q3 2026.
  • Novo Nordisk made up 0.04% of General Partner Inc's portfolio in Q3 2026, its #120 holding.
  • General Partner Inc first reported a position in Novo Nordisk in Q1 2024 and has held it in 11 quarters since.
  • General Partner Inc's Novo Nordisk position peaked at $144K in Q1 2025.
  • 338 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on General Partner Inc's 13F filing for Q3 2026, filed 5 Oct 2026.